Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Classification in Relation to Prevention of Endometrial Cancer Recurrence and Lifestyle Factors

NCT06680791 is registered in ClinicalTrials.gov with Lukas Vanek as lead sponsor.

NCT NCT06680791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06680791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Classification in Relation to Prevention of Endometrial Cancer Recurrence and Lifestyle Factors
Lead sponsor
Lukas Vanek
Phase
Observational
Overall status
Recruiting
Start date
July 15, 2024
Completion date
December 31, 2028
Enrollment
280 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer, genetic predisposition, risk behavior